Can medical marijuana, in the right dosage, effectively treat PTSD and be a solid substitute for opioids as a pain-reliever? Finding out is the goal of a new study involving the Yale University School of Medicine and medical marijuana producer CTPharma (CT Pharmaceutical Solutions), based in Portland.
Guests:
Tom Schultz, Chief Executive Officer, CTPharma
Rino Ferrarese, Chief Operating Officer, CTPharma